The Role of Support in Cancer Survivorship
Amy Selly, CNP, AOCNP, discusses the role support plays in the cancer survivor experience.
Support plays a crucial role in the cancer survivorship experience, providing emotional, social, and practical assistance to patients throughout their journey. Emotional support can help reduce stress and anxiety, provide a sense of belonging, and offer hope and encouragement. Social support helps maintain relationships, offers practical assistance, and reduces feeling of isolation. Practical support provides information and resources, advocates for survivors, and helps navigate the health care system.
Support is essential for cancer survivors. By connecting with others who understand their experiences, cancer survivors can find strength, hope, and a sense of community.
Here, Amy Selly, CNP, AOCNP, Allina Health medical oncology advanced practice provider lead, discusses the discusses the importance and impact of support on the cancer survivor journey.
Transcription:
0:05 | It's a major impact on how the patients move through their cancer journey. Strong, strong social support. Through us working anecdotally with patients and through research has showed that it can really help a patient have a more positive experience with their cancer diagnosis, that it will build better resiliency with them as they move forward. It provides comfort and it improves their coping as they're moving through the cancer. And I think it's equally important to talk about the low when patients have low level of support.
0:42 | With those patients, we see higher levels of depression. We see lower functional statuses with them. We see more symptoms and side effects from the treatment. We also see more challenges with getting them initially through treatment, so, you know, making it to the appointments, as well as having long-term follow up and moving through that surveillance period to help make sure that we're giving them all of the tools that they need to be successful moving forward.
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
